HER2-Specific Targeted Toxin DARPin-LoPE

Immunogenicity and Antitumor Effect on Intraperitoneal Ovarian Cancer Xenograft Model

Evgeniya A. Sokolova, Olga N. Shilova, Daria V. Kiseleva, Alexey A. Schulga, Irina V. Balalaeva, Sergey M. Deyev

Research output: Contribution to journalArticle

Abstract

High immunogenicity and systemic toxicity are the main obstacles limiting the clinical use of the therapeutic agents based on Pseudomonas aeruginosa exotoxin A. In this work, we studied the immunogenicity, general toxicity and antitumor effect of the targeted toxin DARPin-LoPE composed of HER2-specific DARPin and a low immunogenic exotoxin A fragment lacking immunodominant human B lymphocyte epitopes. The targeted toxin has been shown to effectively inhibit the growth of HER2-positive human ovarian carcinoma xenografts, while exhibiting low non-specific toxicity and side effects, such as vascular leak syndrome and liver tissue degradation, as well as low immunogenicity, as was shown by specific antibody titer. This represents prospects for its use as an agent for targeted therapy of HER2-positive tumors.

Original languageEnglish
JournalInternational Journal of Molecular Sciences
Volume20
Issue number10
DOIs
Publication statusPublished - 15 May 2019

Fingerprint

Immunotoxins
Heterografts
toxicity
Ovarian Neoplasms
Toxicity
cancer
B-Lymphocyte Epitopes
Exotoxins
Therapeutic Uses
Blood Vessels
Epitopes
pseudomonas
Lymphocytes
lymphocytes
Carcinoma
antibodies
liver
Antibodies
Liver
Tumors

Keywords

  • DARPin
  • far-red fluorescent protein
  • HER2
  • immunogenicity
  • ovarian carcinoma
  • Pseudomonas exotoxin A
  • targeted therapy

ASJC Scopus subject areas

  • Catalysis
  • Molecular Biology
  • Spectroscopy
  • Computer Science Applications
  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Inorganic Chemistry

Cite this

HER2-Specific Targeted Toxin DARPin-LoPE : Immunogenicity and Antitumor Effect on Intraperitoneal Ovarian Cancer Xenograft Model. / Sokolova, Evgeniya A.; Shilova, Olga N.; Kiseleva, Daria V.; Schulga, Alexey A.; Balalaeva, Irina V.; Deyev, Sergey M.

In: International Journal of Molecular Sciences, Vol. 20, No. 10, 15.05.2019.

Research output: Contribution to journalArticle

Sokolova, Evgeniya A. ; Shilova, Olga N. ; Kiseleva, Daria V. ; Schulga, Alexey A. ; Balalaeva, Irina V. ; Deyev, Sergey M. / HER2-Specific Targeted Toxin DARPin-LoPE : Immunogenicity and Antitumor Effect on Intraperitoneal Ovarian Cancer Xenograft Model. In: International Journal of Molecular Sciences. 2019 ; Vol. 20, No. 10.
@article{98b8541e4fcb45b78c8fba798f446355,
title = "HER2-Specific Targeted Toxin DARPin-LoPE: Immunogenicity and Antitumor Effect on Intraperitoneal Ovarian Cancer Xenograft Model",
abstract = "High immunogenicity and systemic toxicity are the main obstacles limiting the clinical use of the therapeutic agents based on Pseudomonas aeruginosa exotoxin A. In this work, we studied the immunogenicity, general toxicity and antitumor effect of the targeted toxin DARPin-LoPE composed of HER2-specific DARPin and a low immunogenic exotoxin A fragment lacking immunodominant human B lymphocyte epitopes. The targeted toxin has been shown to effectively inhibit the growth of HER2-positive human ovarian carcinoma xenografts, while exhibiting low non-specific toxicity and side effects, such as vascular leak syndrome and liver tissue degradation, as well as low immunogenicity, as was shown by specific antibody titer. This represents prospects for its use as an agent for targeted therapy of HER2-positive tumors.",
keywords = "DARPin, far-red fluorescent protein, HER2, immunogenicity, ovarian carcinoma, Pseudomonas exotoxin A, targeted therapy",
author = "Sokolova, {Evgeniya A.} and Shilova, {Olga N.} and Kiseleva, {Daria V.} and Schulga, {Alexey A.} and Balalaeva, {Irina V.} and Deyev, {Sergey M.}",
year = "2019",
month = "5",
day = "15",
doi = "10.3390/ijms20102399",
language = "English",
volume = "20",
journal = "International Journal of Molecular Sciences",
issn = "1661-6596",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "10",

}

TY - JOUR

T1 - HER2-Specific Targeted Toxin DARPin-LoPE

T2 - Immunogenicity and Antitumor Effect on Intraperitoneal Ovarian Cancer Xenograft Model

AU - Sokolova, Evgeniya A.

AU - Shilova, Olga N.

AU - Kiseleva, Daria V.

AU - Schulga, Alexey A.

AU - Balalaeva, Irina V.

AU - Deyev, Sergey M.

PY - 2019/5/15

Y1 - 2019/5/15

N2 - High immunogenicity and systemic toxicity are the main obstacles limiting the clinical use of the therapeutic agents based on Pseudomonas aeruginosa exotoxin A. In this work, we studied the immunogenicity, general toxicity and antitumor effect of the targeted toxin DARPin-LoPE composed of HER2-specific DARPin and a low immunogenic exotoxin A fragment lacking immunodominant human B lymphocyte epitopes. The targeted toxin has been shown to effectively inhibit the growth of HER2-positive human ovarian carcinoma xenografts, while exhibiting low non-specific toxicity and side effects, such as vascular leak syndrome and liver tissue degradation, as well as low immunogenicity, as was shown by specific antibody titer. This represents prospects for its use as an agent for targeted therapy of HER2-positive tumors.

AB - High immunogenicity and systemic toxicity are the main obstacles limiting the clinical use of the therapeutic agents based on Pseudomonas aeruginosa exotoxin A. In this work, we studied the immunogenicity, general toxicity and antitumor effect of the targeted toxin DARPin-LoPE composed of HER2-specific DARPin and a low immunogenic exotoxin A fragment lacking immunodominant human B lymphocyte epitopes. The targeted toxin has been shown to effectively inhibit the growth of HER2-positive human ovarian carcinoma xenografts, while exhibiting low non-specific toxicity and side effects, such as vascular leak syndrome and liver tissue degradation, as well as low immunogenicity, as was shown by specific antibody titer. This represents prospects for its use as an agent for targeted therapy of HER2-positive tumors.

KW - DARPin

KW - far-red fluorescent protein

KW - HER2

KW - immunogenicity

KW - ovarian carcinoma

KW - Pseudomonas exotoxin A

KW - targeted therapy

UR - http://www.scopus.com/inward/record.url?scp=85066823921&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066823921&partnerID=8YFLogxK

U2 - 10.3390/ijms20102399

DO - 10.3390/ijms20102399

M3 - Article

VL - 20

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

SN - 1661-6596

IS - 10

ER -